Trial intelligence / Profile preview

Propranolol vs Acebutolol in Infantile Hemangioma

NCT01743885Phase 3Terminated

Sponsor
CHU Montpellier
Start
Nov 2012
Primary completion
Jun 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of acebutolol in infantile hemangioma (IH), sponsored by CHU Montpellier. Started Nov 2012; status: terminated.

02

Drugs

acebutolol
03

Conditions

infantile hemangioma (IH)

Beyond the preview

Go deeper on NCT01743885.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01743885.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call